CLINICAL USE OF INTERMEDIATE TO HIGH-DOSE OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN CHILDREN WITH ACUTE-LEUKEMIA

被引：2
|
作者：
TAKASHIMA, Y [1 ]
机构：
[1] MEIJO HOSP,PEDIAT CLIN,FEDERAT NATL PUBL SERV PERSONNEL MUTUAL AID ASSOC,NAKA KU,NAGOYA 460,JAPAN
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 28卷 / 04期
关键词：
D O I：
10.1002/j.1552-4604.1988.tb03158.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：356 / 362
页数：7
相关论文
共 50 条
  • [41] High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphatic leukemia
    Cohen, Ian J.
    BLOOD, 2008, 112 (03) : 910 - 910
  • [42] High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia
    von Stackelberg, Arend
    Hartmann, Reinhard
    Buehrer, Christoph
    Fengler, Ruediger
    Janka-Schaub, Gritta
    Reiter, Alfred
    Mann, Georg
    Schmiegelow, Kjeld
    Ratei, Richard
    Klingebiel, Thomas
    Ritter, Joerg
    Henze, Guenter
    BLOOD, 2008, 111 (05) : 2573 - 2580
  • [43] A clinical report on high-dose cytarabine therapy for children with acute myeloid leukemia
    Wu, Ziliang
    Wu, Zelin
    Zou, Yawei
    Guan, Jingming
    Wu, Shangzhi
    Chen, Dehui
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 17 (05)
  • [44] TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA BY CONCURRENT ADMINISTRATION OF N-4-BEHENOYL-L-BETA-D-ARABINOFURANOSYLCYTOSINE, ACLACINOMYCIN-A, 6-MERCAPTOPURINE AND PREDNISOLONE - A PILOT-STUDY
    HIRANO, M
    MORISHITA, Y
    INO, T
    MATSUI, T
    SHIMIZU, S
    SHIGEMURA, H
    NAKAMURA, K
    ONO, Y
    SAITO, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1981, 11 (01) : 87 - 92
  • [45] CLINICAL-EVIDENCE OF A CUMULATIVE EFFECT OF HIGH-DOSE CYTARABINE ON THE CEREBELLUM IN PATIENTS WITH ACUTE-LEUKEMIA - A LEUKEMIA INTERGROUP REPORT
    BENGER, A
    BROWMAN, GP
    WALKER, IR
    PREISLER, HD
    GOLDBERG, J
    CANCER TREATMENT REPORTS, 1985, 69 (02): : 240 - 241
  • [46] CONTINUOUS INFUSION OF HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE - A PHASE-I AND PHARMACOLOGICAL STUDY
    SPRIGGS, DR
    ROBBINS, G
    TAKVORIAN, T
    KUFE, DW
    CANCER RESEARCH, 1985, 45 (08) : 3932 - 3936
  • [47] INVIVO CELLULAR KINETIC AND PHARMACOLOGICAL STUDIES OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND 3-DEAZAURIDINE CHEMOTHERAPY FOR RELAPSING ACUTE-LEUKEMIA
    BARLOGIE, B
    PLUNKETT, W
    RABER, M
    LATREILLE, J
    KEATING, M
    MCCREDIE, K
    CANCER RESEARCH, 1981, 41 (03) : 1227 - 1235
  • [48] PHASE-I CLINICAL AND PHARMACOKINETIC EVALUATION OF HIGH-DOSE MITOXANTRONE IN COMBINATION WITH CYTARABINE IN PATIENTS WITH ACUTE-LEUKEMIA
    FELDMAN, EJ
    ALBERTS, DS
    ARLIN, Z
    AHMED, T
    MITTELMAN, A
    BASKIND, P
    PENG, YM
    BAIER, M
    PLEZIA, P
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) : 2002 - 2009
  • [49] SCHEDULE-DEPENDENT SYNERGY AND ANTAGONISM BETWEEN HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND ASPARAGINASE IN THE L5178Y MURINE LEUKEMIA
    SCHWARTZ, SA
    MORGENSTERN, B
    CAPIZZI, RL
    CANCER RESEARCH, 1982, 42 (06) : 2191 - 2197
  • [50] THE SIMULTANEOUS DETERMINATION OF ARA-U AND ARA-C, URINARY METABOLITES OF N4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE BY MASS FRAGMENTOGRAPHY
    MAKINO, Y
    MATSUBARA, Y
    WATANABE, K
    HIROBE, M
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1982, 102 (01): : 49 - 55
12345